Sunrest Lifescience Ltd

AI
Sunrest Lifescie Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Sunrest Lifescience Ltd

₹ 33.5 -4.29%
23 Oct - close price
sunrestlifescience.com NSE - SME: SUNREST
About

Incorporated in 2017, Sunrest Lifescience Ltd trades in Health care and Cosmetics products[1]

Key Points

Business Overview:[1][2]
SLSL is in the business of trading of Pharmaceutical Product on wholesale and retail basis. It provides OTC brands in healthcare & personal care viz. Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste

Website NSE - SM
  • Market Cap ₹ 14.4 Cr.
  • Current Price ₹ 33.5
  • High / Low ₹ 54.0 / 29.6
  • Stock P/E 5.16
  • Book Value ₹ 47.6
  • Dividend Yield 0.00 %
  • ROCE 23.2 %
  • ROE 15.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.70 times its book value
  • Debtor days have improved from 283 to 168 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has high debtors of 168 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024 Sep 2025 Mar 2026
15.39 34.01 36.82
14.48 31.56 30.07
Operating Profit 0.91 2.45 6.75
OPM % 5.91% 7.20% 18.33%
0.00 0.00 2.51
Interest 0.12 0.72 0.70
Depreciation 0.01 0.68 0.51
Profit before tax 0.78 1.05 8.05
Tax % 24.36% 37.14% 18.51%
0.58 0.66 6.57
EPS in Rs 1.35 0.79 7.88
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
33.41 70.63
30.38 60.42
Operating Profit 3.03 10.21
OPM % 9.07% 14.46%
0.00 2.51
Interest 0.31 1.42
Depreciation 0.10 1.19
Profit before tax 2.62 10.11
Tax % 23.28% 20.87%
2.02 8.00
EPS in Rs 4.68 9.60
Dividend Payout % 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 111%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 39%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -20%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Equity Capital 4.29 4.29
Reserves 12.02 16.14
12.06 17.46
30.28 33.52
Total Liabilities 58.65 71.41
4.36 8.55
CWIP 0.00 0.00
Investments 0.00 0.00
54.29 62.86
Total Assets 58.65 71.41

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
2.92 -0.05
-1.15 -2.91
-0.33 3.99
Net Cash Flow 1.45 1.03
Free Cash Flow 1.76 -2.76
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 112% 14%

Ratios

Consolidated / View Standalone

Mar 2025 Mar 2026
Debtor Days 397.34 167.75
Inventory Days 174.87 140.69
Days Payable 416.81 173.35
Cash Conversion Cycle 155.40 135.09
Working Capital Days 228.33 156.33
ROCE % 23.22%

Insights

In beta
Mar 2023 Mar 2024 Mar 2025 Mar 2026
Purchases of Stock-in-Trade
INR Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Stock-in-Trade (Inventory, closing balance)
INR Lakhs ・Standalone data
Permanent Employees
count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
69.91% 69.91% 69.91% 69.91% 69.91% 54.00% 53.50% 53.50% 53.50% 53.50%
30.09% 30.09% 30.09% 30.09% 30.09% 47.00% 46.50% 46.50% 46.50% 46.50%
No. of Shareholders 580505487459455498491492484484

Documents

Announcements

Annual reports

DRHP